Simon W Rabkin1. 1. Professor of Medicine (Cardiology), Department of Medicine (Cardiology), University of British Columbia, Vancouver, British Columbia.
Abstract
OBJECTIVE: To assess older age and female sex, 2 of the major risk factors for potentially fatal cardiac arrhythmias or sudden cardiac death in patients prescribed psychotropics, within the context of electrocardiographic evidence of time between start of Q wave and end of T wave (QT) interval prolongation, which is an indicator of an increased risk for potentially fatal cardiac arrhythmias. METHOD: The literature on the relation between age, sex, and QT interval with respect to psychotropic drugs was reviewed. RESULTS: The QT interval must be corrected (QTc) for heart rate. Because slower heart rates prolong and faster heart rates shorten the QT interval, people with faster heart rates may have a prolonged QT interval that is not apparent until the correction is performed. QTc values for apparently healthy post-pubertal people are less than 450 ms for males and less than 470 ms for females. The longer QT intervals in women may account for their increased risk of potentially fatal cardiac arrhythmias on psychotropics. QTc increases with increasing age. Assessment of QTc in older people is especially important to identify people with a longer QTc who are more likely to attain a serious QT level with drugs that prolong QTc. The age-related increase in QTc is more evident in men than women, suggesting that male sex does not afford protection against potentially fatal arrhythmias at older age. CONCLUSION: The association of increasing age and female sex with greater QT intervals indicates the need to have an increased awareness of the QTc prior to use of these psychotropics and to evaluate the QTc after initiation of therapy.
OBJECTIVE: To assess older age and female sex, 2 of the major risk factors for potentially fatal cardiac arrhythmias or sudden cardiac death in patients prescribed psychotropics, within the context of electrocardiographic evidence of time between start of Q wave and end of T wave (QT) interval prolongation, which is an indicator of an increased risk for potentially fatal cardiac arrhythmias. METHOD: The literature on the relation between age, sex, and QT interval with respect to psychotropic drugs was reviewed. RESULTS: The QT interval must be corrected (QTc) for heart rate. Because slower heart rates prolong and faster heart rates shorten the QT interval, people with faster heart rates may have a prolonged QT interval that is not apparent until the correction is performed. QTc values for apparently healthy post-pubertal people are less than 450 ms for males and less than 470 ms for females. The longer QT intervals in women may account for their increased risk of potentially fatal cardiac arrhythmias on psychotropics. QTc increases with increasing age. Assessment of QTc in older people is especially important to identify people with a longer QTc who are more likely to attain a serious QT level with drugs that prolong QTc. The age-related increase in QTc is more evident in men than women, suggesting that male sex does not afford protection against potentially fatal arrhythmias at older age. CONCLUSION: The association of increasing age and female sex with greater QT intervals indicates the need to have an increased awareness of the QTc prior to use of these psychotropics and to evaluate the QTc after initiation of therapy.
Authors: David W Hough; Jaya Natarajan; An Vandebosch; Stefan Rossenu; Michelle Kramer; Mariëlle Eerdekens Journal: Int Clin Psychopharmacol Date: 2011-01 Impact factor: 1.659
Authors: A L Nyth; C G Gottfries; K Lyby; L Smedegaard-Andersen; J Gylding-Sabroe; M Kristensen; H E Refsum; E Ofsti; S Eriksson; S Syversen Journal: Acta Psychiatr Scand Date: 1992-08 Impact factor: 6.392
Authors: Ingrid M M van Haelst; Wilton A van Klei; Hieronymus J Doodeman; Miriam J Warnier; Marie L De Bruin; Cor J Kalkman; Toine C G Egberts Journal: J Clin Psychiatry Date: 2014-01 Impact factor: 4.384
Authors: Paula A Rochon; Andrea Gruneir; Sudeep S Gill; Wei Wu; Hadas D Fischer; Susan E Bronskill; Sharon-Lise T Normand; Peter C Austin; Dallas P Seitz; Chaim M Bell; Longdi Fu; Lorraine Lipscombe; Geoffrey M Anderson; Jerry H Gurwitz Journal: J Am Geriatr Soc Date: 2013-01-10 Impact factor: 5.562
Authors: Lea T Drye; David Spragg; D P Devanand; Constantine Frangakis; Christopher Marano; Curtis L Meinert; Jacobo E Mintzer; Cynthia A Munro; Gregory Pelton; Bruce G Pollock; Anton P Porsteinsson; Peter V Rabins; Paul B Rosenberg; Lon S Schneider; David M Shade; Daniel Weintraub; Jerome Yesavage; Constantine G Lyketsos Journal: PLoS One Date: 2014-06-10 Impact factor: 3.240
Authors: Andreas D Meid; Anna von Medem; Dirk Heider; Jürgen-Bernhard Adler; Christian Günster; Hanna M Seidling; Renate Quinzler; Hans-Helmut König; Walter E Haefeli Journal: Drug Saf Date: 2017-02 Impact factor: 5.606
Authors: Tarek Magdy; Adam J T Schuldt; Joseph C Wu; Daniel Bernstein; Paul W Burridge Journal: Annu Rev Pharmacol Toxicol Date: 2017-10-06 Impact factor: 13.820
Authors: Andreas D Meid; Irene Bighelli; Sarah Mächler; Gerd Mikus; Giuseppe Carrà; Mariasole Castellazzi; Claudio Lucii; Giovanni Martinotti; Michela Nosè; Giovanni Ostuzzi; Corrado Barbui; Walter E Haefeli Journal: Ther Adv Psychopharmacol Date: 2017-08-28